University Hospital Münster, Klinik für Neurochirurgie
Welcome,         Profile    Billing    Logout  
 1 Trial 
10 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Eich, Hans Th
ALA-RDTinGBM, NCT05590689 / 2021-004631-92: Radiodynamic Therapy (RDT) With Gliolan in Patients With First Recurrence of Brain Tumor

Recruiting
1/2
34
Europe
Gliolan, 5-Aminolevulinic acid, Radiodynamic therapy
Universität Münster, photonamic GmbH & Co. KG
Glioblastoma
06/26
01/27
Stummer, Walter
MEN-301, NCT04305470 / 2020-000096-21: Gleolan for Visualization of Newly Diagnosed or Recurrent Meningioma

Completed
3
108
Europe, US
Gleolan (Aminolevulinic Acid Hydrochloride/ALA/ALA-HCI)
NX Development Corp, NX Development Corp.
Meningioma
11/22
12/22
NCT03897491: PD L 506 for Stereotactic Interstitial Photodynamic Therapy of Newly Diagnosed Supratentorial IDH Wild-type Glioblastoma

Recruiting
2
20
Europe
5-aminolevulinic acid
photonamic GmbH & Co. KG
Glioblastoma
03/24
03/27
NCT04738162 / 2014-005669-54: Clinical Safety Study on 5-Aminolevulinic Acid (5-ALA) in Children and Adolescents With Brain Tumors

Recruiting
2
80
Europe
5-Aminolevulinic Acid Hydrochloride, Oral, Gliolan
Universität Münster, photonamic GmbH & Co. KG, medac GmbH
Brain Tumor, Pediatric
06/25
06/25
NOA11, NCT04469699: Stereotactical Photodynamic Therapy With 5-aminolevulinic Acid (Gliolan®) in Recurrent Glioblastoma

Recruiting
2
106
Europe
Stereotactic biopsy followed by stereotactical photodynamic therapy with 5-aminolevulinic acid, Gliolan, 5-aminolevulinic acid, Stereotactic biopsy
University Hospital Muenster, Deutsche Krebshilfe e.V., Bonn (Germany), photonamic GmbH & Co. KG, medac GmbH, LifePhotonic GmbH
Glioblastoma Multiforme, Adult
04/26
04/26
ALA-RDTinGBM, NCT05590689 / 2021-004631-92: Radiodynamic Therapy (RDT) With Gliolan in Patients With First Recurrence of Brain Tumor

Recruiting
1/2
34
Europe
Gliolan, 5-Aminolevulinic acid, Radiodynamic therapy
Universität Münster, photonamic GmbH & Co. KG
Glioblastoma
06/26
01/27
RIT in GBM, NCT05533242: Radioimmunotherapy With Lu-177 Labeled 6A10 Fab-fragments in Patients With Glioblastoma After Standard Treatment

Recruiting
1
15
Europe
Lu-177 labeled 6A10-Fab-fragments
University Hospital Muenster, Isotope Technologies Munich (ITM) Oncologics, Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)
Glioblastom WHO Grade 4
06/25
06/25
NCT06665724: Clinical Trial Evaluating Safety of 5-Aminolevulinic Acid (5-ALA) Combined with CV01 Delivery of Ultrasound for Sonodynamic Therapy (SDT) in Patients with Newly Diagnosed High-Grade Glioma (HGG) Prior to Resection and Standard Adjuvant Therapy (ALA SDT GLIOMA 401)

Not yet recruiting
1
14
Europe
5-Aminolevulinic acid Hydrochloride (Gliolan®), CV01
Universität Münster, Alpheus Medical, Inc.
Anaplastic Astrocytoma (AA), Anaplastic Oligodendroglioma (AO), Glioblastoma (GBM)
01/26
01/26
Dammann, Philip
NCT04738162 / 2014-005669-54: Clinical Safety Study on 5-Aminolevulinic Acid (5-ALA) in Children and Adolescents With Brain Tumors

Recruiting
2
80
Europe
5-Aminolevulinic Acid Hydrochloride, Oral, Gliolan
Universität Münster, photonamic GmbH & Co. KG, medac GmbH
Brain Tumor, Pediatric
06/25
06/25
Schwake, Michael
NCT04738162 / 2014-005669-54: Clinical Safety Study on 5-Aminolevulinic Acid (5-ALA) in Children and Adolescents With Brain Tumors

Recruiting
2
80
Europe
5-Aminolevulinic Acid Hydrochloride, Oral, Gliolan
Universität Münster, photonamic GmbH & Co. KG, medac GmbH
Brain Tumor, Pediatric
06/25
06/25

Download Options